XCHG (XCH) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
17 Dec, 2025Executive summary
Q2 2024 saw resilient operational performance despite macroeconomic challenges, with a focus on innovation and R&D investment.
IPO in September 2024 raised $19.1 million in net proceeds, supporting future growth initiatives.
Financial highlights
Q2 2024 revenues were $9.0 million, down 26.3% year-over-year, mainly due to lower deliveries to a major European customer.
Gross profit for Q2 2024 was $4.2 million, with a gross margin of 46.1%, up from 44.7% in Q2 2023 due to enhanced cost controls.
Operating loss was $0.9 million in Q2 2024, compared to operating income of $2.1 million in Q2 2023.
Net loss attributable to ordinary shareholders was $1.3 million in Q2 2024, versus net income of $0.5 million in Q2 2023.
Cash and cash equivalents increased to $24.3 million as of June 30, 2024, from $12.8 million as of March 31, 2024.
Outlook and guidance
Management remains committed to R&D investment and global expansion, aiming to create new commercialization opportunities and strengthen market leadership.
Latest events from XCHG
- Auditor consents updated for a public offering led by CEO Yifei Hou and U.S. President Aatish V. Patel.XCH
Registration Filing29 Jan 2026 - EV charging tech leader seeks to raise $250M via flexible securities offering amid China risks.XCH
Registration Filing19 Dec 2025 - IPO targets $15.2M for US expansion; rapid growth, high margins, but significant risks.XCH
Registration Filing29 Nov 2025 - EV charging leader targets U.S. IPO to fund expansion, R&D, and U.S. manufacturing.XCH
Registration Filing29 Nov 2025 - IPO targets $16.7M for US plant, R&D, and expansion; strong growth, but faces losses and regulatory risks.XCH
Registration Filing29 Nov 2025 - IPO targets $16.7M to fund U.S. plant, R&D, and global growth; strong margins, high regulatory risk.XCH
Registration Filing29 Nov 2025 - Revenue and deliveries declined sharply, but long-term outlook remains positive.XCH
H1 202523 Sep 2025